关注
Roger Belizaire
Roger Belizaire
Dana-Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Altered proteasomal function in sporadic Parkinson's disease
KSP McNaught, R Belizaire, O Isacson, P Jenner, CW Olanow
Experimental neurology 179 (1), 38-46, 2003
8042003
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
D Heckl, MS Kowalczyk, D Yudovich, R Belizaire, RV Puram, ...
Nature biotechnology 32 (9), 941-946, 2014
6282014
Proteasome inhibition causes nigral degeneration with inclusion bodies in rats
KSP McNaught, LM Björklund, R Belizaire, O Isacson, P Jenner, ...
Neuroreport 13 (11), 1437-1441, 2002
3672002
Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease
KSP McNaught, R Belizaire, P Jenner, CW Olanow, O Isacson
Neuroscience letters 326 (3), 155-158, 2002
3142002
CD8α+ dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes
BT Edelson, TR Bradstreet, K Hildner, JA Carrero, KE Frederick, ...
Immunity 35 (2), 236-248, 2011
2102011
Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation
R Belizaire, ER Unanue
Proceedings of the National Academy of Sciences 106 (41), 17463-17468, 2009
1562009
Multiplex CRISPR/Cas9-based genome editing in human hematopoietic stem cells models clonal hematopoiesis and myeloid neoplasia
Z Tothova, JM Krill-Burger, KD Popova, CC Landers, QL Sievers, ...
Cell Stem Cell 21 (4), 547-555. e8, 2017
992017
Salt accelerates allograft rejection through serum-and glucocorticoid-regulated Kinase-1–dependent inhibition of regulatory T cells
K Safa, S Ohori, TJ Borges, M Uehara, I Batal, T Shimizu, CN Magee, ...
Journal of the American Society of Nephrology 26 (10), 2341-2347, 2015
512015
Clonal haematopoiesis and dysregulation of the immune system
R Belizaire, WJ Wong, ML Robinette, BL Ebert
Nature Reviews Immunology 23 (9), 595-610, 2023
502023
Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain
F Cicchetti, L Costantini, R Belizaire, W Burton, O Isacson, W Fodor
Experimental neurology 177 (2), 376-384, 2002
462002
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease
R Belizaire, HT Kim, SJ Poryanda, NV Mirkovic, E Hipolito, WJ Savage, ...
Blood advances 3 (7), 969-979, 2019
352019
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1
R Belizaire, SHJ Koochaki, ND Udeshi, A Vedder, L Sun, T Svinkina, ...
Blood, The Journal of the American Society of Hematology 137 (16), 2209-2220, 2021
312021
ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling
DB Graham, HM Akilesh, GB Gmyrek, L Piccio, S Gilfillan, J Sim, ...
Blood, The Journal of the American Society of Hematology 116 (17), 3208-3218, 2010
232010
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
JM Tsai, JD Aguirre, YD Li, J Brown, V Focht, L Kater, G Kempf, ...
Molecular cell 83 (15), 2753-2767. e10, 2023
222023
Non-alloimmune mechanisms of thrombocytopenia and refractoriness to platelet transfusion
R Belizaire, RS Makar
Transfusion Medicine Reviews 34 (4), 242-249, 2020
202020
Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens
R Belizaire, J Mack, S Kadauke, Y Kim, S Saidman, RS Makar
Transfusion 59 (7), 2256-2263, 2019
192019
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency
R Belizaire, DB Sykes, YBA Chen, TR Spitzer, RS Makar
Transfusion 55 (9), 2142-2148, 2015
122015
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
J Versluis, M Pandey, Y Flamand, JE Haydu, R Belizaire, M Faber, ...
Blood Advances 6 (9), 2835-2846, 2022
92022
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML
EC Wheeler, BJE Martin, WC Doyle, S Neaher, CA Conway, CN Pitton, ...
Science translational medicine 16 (728), eade2774, 2024
82024
Low-dose interleukin-2 therapy enhances cytotoxicity of CD56bright NK cells in patients with chronic GvHD
T Kubo, R Romee, J Koreth, R Belizaire, Y Kamihara, H Liu, T Asano, ...
Blood 132, 606, 2018
52018
系统目前无法执行此操作,请稍后再试。
文章 1–20